Healthcare & Life Sciences
Obulytix
Belgium
seed
seed
Stage
2
Investors
About
Obulytix develops next-generation enzyme-based antibiotics inspired by natural compounds as a spin-out from Ghent University.
Explore Obulytix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.